IGR_MITF_STUDY_BBRB
Ontology highlight
ABSTRACT: A recent study of the characteristics of coexisting melanoma and renal cell carcinoma RCC in the same patients supports a genetic predisposition underlying the association between these two cancers. The microphthalmia associated transcription factor (MITF) was proposed to act as a melanoma oncogene; it also stimulates the transcription of hypoxia inducible factor (HIF1A), whose pathway is targeted by kidney cancer susceptibility genes. By sequencing the MITF gene, we detected a germ line missense substitution (p.E318K) in 5 of 62 patients affected with melanoma and RCC. When compared with 1,659 controls, this MITF substitution occurred at a significantly higher frequency in melanoma + RCC patients (p = 1.3x10-4), melanoma -only patients (p = 7.8 x10-5), and RCC-only patients (p = 0.008). Overall, p.E318K substitution carriers had a higher than fivefold increased risk of developing melanoma, RCC or both cancers (odds-ratio = 5.55, 95% confidence interval = 2.59 to 12.91). Codon 318 falls in the second MITF-conserved, small-ubiquitin like modifier (SUMO)-1 consensus binding site (YKXE) and the p.E318K substitution severely impairs SUMOylation of MITF. MITF p.E318K binds more efficiently to the HIF1A promoter and increases its activation compared to the wild type MITF. In RCC cell line, transcriptomic approach identifies a MITF p.E318K signature related to cell growth, proliferation and inflammation. MITF p.E318K is more potent than wild type MITF in promoting melanocytic and renal cell clonogenicity, migration and invasion, consistent with a gain-of-function role in tumorigenesis. Our data provide novel insights on the link between transcription, sumoylation and cancer, possibly mediated by oxidative stress. This set of 26 arrays presents expression data for 3 conditions (reference cell line, with addition of wt MITF or e318K MITF for two different cell lines (melanoma A375 and renal RCC4), in dye swap and 3 independant biological replicates.
ORGANISM(S): Homo sapiens
DISEASE(S): melanoma
SUBMITTER: Philippe DESSEN
PROVIDER: E-TABM-1198 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA